MONOCLONAL ANTIBODIES THAT BIND EGFRVIII AND THEIR USE Read more about MONOCLONAL ANTIBODIES THAT BIND EGFRVIII AND THEIR USE India202217002368Filed on 2020-07-01
MONOCLONAL ANTIBODIES THAT BIND EGFRVIII AND THEIR USE Read more about MONOCLONAL ANTIBODIES THAT BIND EGFRVIII AND THEIR USE Israel289488Filed on 2020-07-01
TRITERPENE AMINE DERIVATIVES Read more about TRITERPENE AMINE DERIVATIVES New Zealand769842Filed on 2020-11-11
NANOPARTICLE TO TARGET CANCER Read more about NANOPARTICLE TO TARGET CANCER US Patent 11,696,922Filed on 2021-12-17
TARGETED CANCER THERAPY Read more about TARGETED CANCER THERAPY US Application 17/528,827Filed on 2021-11-17
HUMAN MONOCLONAL ANTIBODIES SPECIFIC FOR FLT3 AND USES THEREOF Read more about HUMAN MONOCLONAL ANTIBODIES SPECIFIC FOR FLT3 AND USES THEREOF US Patent 12,012,455Filed on 2022-01-06
DENOISING OF DYNAMIC RESONANCE SPECTROSCOPIC IMAGING USING LOW RANK APPROXIMATIONS IN THE KINETIC DOMAIN Read more about DENOISING OF DYNAMIC RESONANCE SPECTROSCOPIC IMAGING USING LOW RANK APPROXIMATIONS IN THE KINETIC DOMAIN US Patent 12,270,881Filed on 2022-01-14
CHIMERIC ANTIGEN RECEPTORS TARGETING GLYPICAN-2 Read more about CHIMERIC ANTIGEN RECEPTORS TARGETING GLYPICAN-2 US Application 17/608,832Filed on 2021-11-04
Fully Human Antibodies Targeting Human GPC2 For Therapeutics Development Read more about Fully Human Antibodies Targeting Human GPC2 For Therapeutics Development Canada3139507Filed on 2020-05-06
HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12R MUTATION Read more about HLA CLASS II-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12R MUTATION Hong Kong62022047561.5Filed on 2022-02-04